Daniel R. Glickman

A director of CME Group Inc. (Nasdaq), Daniel R. Glickman reported seven sales worth EUR 834,147, with a median of EUR 120,187, and no purchase. The three largest are EUR 156,675 on March 1, 2022, EUR 140,800 on August 9, 2023 and EUR 131,266 on August 17, 2020. They stay in a narrow range, like the sales as a whole.

The record comprises 18 filings published from June 29, 2016 to June 26, 2024: 11 share grants and the seven sales, nothing else. The yearly count stays between one and four: 2022 is the fullest with four filings, 2016 and 2021 have just one. No filing falls in the last twelve months. Publication comes a median of 2 days after the trade.

The count of trades by Glickman within 30 days of colleagues at CME Group Inc. is 5, 4 and 3. All on the same side. The colleagues, in the same order: Hilda Harris Piell, Sunil Cutinho and Charles P. Carey.